Vu Truong, Ph.D.Founder, Chief Executive Officer and Director at Aridis Pharmaceuticals
Dr. Truong is a founder of Aridis and elected to the CEO position in 2014 after having served as the company's Chief Scientific Officer for the past 9 years. He has over 20 years of experience in biopharmaceutical drug development, and a life-long interest and research experience in infectious diseases, focusing on the development of innovative human monoclonal antibodies and vaccines designed to address life threatening infections. His product development experience includes FluMist™, Synagis™ mAb, and a number of other monoclonal antibody based therapeutics. Dr. Truong is the principal architect of the Aridis technologies, which includes a range of anti-infective products, MabIgX® human mAb discovery platform technology, and pharmaceutical processing technologies. He received his Ph.D. in Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine.